FourWorld Capital Management LLC lessened its stake in Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 18.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,090,851 shares of the biopharmaceutical company’s stock after selling 251,056 shares during the quarter. Arbutus Biopharma comprises approximately 1.8% of FourWorld Capital Management LLC’s investment portfolio, making the […]
FourWorld Capital Management LLC reduced its position in shares of Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 18.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,090,851 shares of the biopharmaceutical company’s stock after selling 251,056 shares during the quarter. Arbutus Biopharma […]
29.05.2024 - WARMINSTER, Pa., May 29, 2024 (GLOBE NEWSWIRE) - Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B .
WARMINSTER, Pa., May 22, 2024 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with.
Arbutus to Participate in Two Upcoming Investor Conferences wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.